WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007017262) XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/017262    International Application No.:    PCT/EP2006/007869
Publication Date: 15.02.2007 International Filing Date: 08.08.2006
IPC:
C07D 473/06 (2006.01), C07D 473/04 (2006.01), A61K 31/495 (2006.01), A61P 3/00 (2006.01), A61P 9/00 (2006.01)
Applicants: SMITHKLINE BEECHAM CORPORATION [US/US]; One Franklin Plaza, Po Box 7929, Philadelphia, Pennsylvania 19101 (US) (For All Designated States Except US).
HATLEY, Richard, Jonathan, Daniel [GB/GB]; (GB) (For US Only).
HEER, Jag, Paul [GB/GB]; (GB) (For US Only).
LIDDLE, John [GB/GB]; (GB) (For US Only).
MASON, Andrew, McMurtrie [GB/GB]; (GB) (For US Only).
PINTO, Ivan, Leo [GB/GB]; (GB) (For US Only).
RAHMAN, Shahzad, Sharooq [GB/GB]; (GB) (For US Only).
SMITH, Ian, Edward, David [GB/GB]; (GB) (For US Only)
Inventors: HATLEY, Richard, Jonathan, Daniel; (GB).
HEER, Jag, Paul; (GB).
LIDDLE, John; (GB).
MASON, Andrew, McMurtrie; (GB).
PINTO, Ivan, Leo; (GB).
RAHMAN, Shahzad, Sharooq; (GB).
SMITH, Ian, Edward, David; (GB)
Agent: EASEMAN, Richard, Lewis; GlaxoSmithKline, Corporate Intellectual Property (CN925.1), 980 Great West Road, Brentford Middlesex TW8 9GS (GB)
Priority Data:
0516464.5 10.08.2005 GB
0607736.6 19.04.2006 GB
0614569.2 21.07.2006 GB
Title (EN) XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS
(FR) DERIVES DE XANTHINE EN TANT QU'AGONISTES HM74A SELECTIFS
Abstract: front page image
(EN)The present invention relates to compounds 0f formula (I), which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
(FR)La présente invention concerne des composés de formule (I) qui constituent des dérivés de xanthine, des procédés de fabrication desdits dérivés, des préparations pharmaceutiques contenant les composés actifs et l'utilisation desdits composés en thérapie, par exemple, dans le traitement de maladies, au cours desquelles la sous-activation du récepteur HM74A favorise la maladie ou bien l'activation du récepteur est bénéfique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)